Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

BESIVANCE- besifloxacin suspension

  1. Patient Information
  2. Distributed By:

Patient Information 

Handling the Container

Advise patients to avoid contaminating the applicator tip with material from the eye, fingers or other source.

Use with Contact Lenses

Advise patients not to wear contact lenses if they have signs or symptoms of bacterial conjunctivitis or during the course of therapy with BESIVANCE.

Dosing Instructions

Patients should be instructed to invert closed bottle (upside down) and shake once before each use.

Distributed By: 

Bausch + Lomb, a division of

Valeant Pharmaceuticals North America LLC

Bridgewater, NJ 08807 USA

U.S. Patent Numbers: 6,685,958; 6,699,492; 8,415,342; 8,481,526; 8,604,020 and 8,937,062

Besivance is a trademark of Bausch & Lomb Incorporated or its affiliates. All other product/brand names and/or logos are trademarks of their respective owners.

Bausch & Lomb Incorporated

DuraSite is a trademark of InSite Vision Incorporated.



Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources | Sitemap
2017 © Copyright Questions?
Please contact: